Facilitating Treatment Entry and Family Planning in Substance-using NICU Mothers



Status:Recruiting
Conditions:Psychiatric
Therapuetic Areas:Psychiatry / Psychology
Healthy:No
Age Range:18 - Any
Updated:3/15/2019
Start Date:July 5, 2017
End Date:April 30, 2020
Contact:Angela Stotts, PhD
Email:Angela.L.Stotts@uth.tmc.edu
Phone:(713) 500-7590

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria
The purpose of this pilot study is to assess whether the hospital-based, adaptive behavioral
intervention strategy promotes treatment entry and reduces risk of additional
substance-exposed pregnancies (SEPs), as well as HIV and HCV risks among substance-using NICU
mothers. Additionally, to assess whether the intervention increases use of professional
obstetrical/gynecological resources for contraception to reduce substance-exposed pregnancies
(SEPs).


Inclusion Criteria:

- have an infant in the NICU at Children's Memorial Hermann Hospital (CMHH)

- have a positive urine drug screen at delivery or have an infant with a positive urine
or meconium drug screen or self-reported drug use to a healthcare provider or had a
documented positive drug screen during pregnancy

- have access to a telephone.

Exclusion Criteria:

- currently attending substance abuse treatment

- severe cognitive, and/or psychiatric impairment, per judgment of NICU and research
staff, that precludes cooperation with study protocol

- inability to read, write, speak English or Spanish

- inability or unwillingness to provide signed consent for participation; (5) inability
or unwillingness to meet study requirements.
We found this trial at
1
site
University of Texas Health Science Center at Houston
7000 Fannin St
Houston, Texas 77030
(713) 500-4472
Phone: 713-500-7590
University of Texas Health Science Center at Houston The University of Texas Health Science Center...
?
mi
from
Houston, TX
Click here to add this to my saved trials